INS and diabetes mellitus: Our results indicate that imipramine exacerbates diabetes mellitus complications by reducing serum insulin levels, as evidenced by the fact that chronic imipramine use resulted in a reduced proportion of β-cells in mouse pancreas sections (Figure S4).